<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04873804</url>
  </required_header>
  <id_info>
    <org_study_id>tDCS on DLPFC and PPC</org_study_id>
    <nct_id>NCT04873804</nct_id>
  </id_info>
  <brief_title>The Effect of Transcranial Direct Stimulation on Cognitive Functions of Healthy Adults</brief_title>
  <official_title>The Effect Of Transcranial Direct Stimulation Applied To The Dorsolateral Prefrontal Cortex And Posterior Parietal Cortex İn Cognitive Function, Mood And Proprioception İn Healthy Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medipol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medipol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Transcranial direct current stimulation(tDCS) has been used to improve cognitive&#xD;
      functions in healthy young adults.&#xD;
&#xD;
      Purpose: To investigate the effect of TDCS application on different cortex regions on&#xD;
      cognitive function.&#xD;
&#xD;
      Methods: Sixty individuals aged 18-30 were included in the study. The participants were&#xD;
      randomly divided into the left dorsolateral prefrontal cortex (Left DLPFC Group)(n=20), the&#xD;
      right posterior parietal cortex (Right PPC Group)(n=20), and the sham group (Sham&#xD;
      Group)(n=20). tDCS was applied for 20 minutes on weekdays for 2 weeks. The participants were&#xD;
      evaluated in terms of cognitive functions with Neuropsychometric Test Battery before and&#xD;
      after treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 10, 2019</start_date>
  <completion_date type="Actual">June 10, 2020</completion_date>
  <primary_completion_date type="Actual">May 10, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neuropsychiatric Test Battery</measure>
    <time_frame>3 weeks</time_frame>
    <description>It is a test battery for getting detailed information about general cognitive status.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Beck Depression Scale</measure>
    <time_frame>3 weeks</time_frame>
    <description>It measures the symptoms seen in depression such as emotional, cognitive and motivational. It includes 21 items determine a behavioral feature related to depression. Items are numbered from 0 to 3. The goal is to objectively break down the degree of symptoms.&#xD;
The total score of all answers is calculated as follows:&#xD;
0 to 9 points: Minimally depressive symptoms 10 to 16 points: Mild depressive symptoms Between 17 and 29 points: Moderate depressive symptoms Between 30 and 63 points: Severe depressive symptoms</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">57</enrollment>
  <condition>Cognitive Symptom</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>LEFT DLPFC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The anode electrode of tDCS was applied to the left DLPFC and the cathode electrode was connected to the contralateral shoulder.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RİGHT PPC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The anode electrode of tDCS was applied to the right PPC and the cathode electrode was connected to the contralateral shoulder.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Placebo was applied by placing the electrodes in the right PPC and left DLPFC without applying current.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Transcranial Direct Current Stimulation</intervention_name>
    <description>The intervention protocols were applied using tDCS (Teknofil TESsaNova). All individuals received 2 mA of anodal tDCS for 2 weeks on weekdays. All applications were done in the form of 20-minute sessions.</description>
    <arm_group_label>LEFT DLPFC</arm_group_label>
    <arm_group_label>RİGHT PPC</arm_group_label>
    <arm_group_label>Sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  being 18-30 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  alcohol and substance addiction&#xD;
&#xD;
          -  previous mental illness&#xD;
&#xD;
          -  having mental and cognitive problems&#xD;
&#xD;
          -  a history of head trauma&#xD;
&#xD;
          -  having cardiovascular disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miray Budak, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medipol University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lutfu Hanoglu, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Medipol University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Damla Ören</name>
      <address>
        <city>Istanbul</city>
        <zip>34000</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medipol Mega Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34000</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 14, 2021</study_first_submitted>
  <study_first_submitted_qc>May 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2021</study_first_posted>
  <last_update_submitted>May 4, 2021</last_update_submitted>
  <last_update_submitted_qc>May 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medipol University</investigator_affiliation>
    <investigator_full_name>Damla Ören</investigator_full_name>
    <investigator_title>Physiotherapist MSc</investigator_title>
  </responsible_party>
  <keyword>tDCS</keyword>
  <keyword>Dorsolateral Prefrontal Cortex</keyword>
  <keyword>Posterior Parietal Cortex</keyword>
  <keyword>Cognitive Function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neurobehavioral Manifestations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

